Related Experiment Video

Updated: Oct 15, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement

A Pugliese1, D Isnardi, A Saini

  • 1Department of Medical and Surgical Sciences, Ospedale Amedeo di Savoia, University of Turin, Italy.

The Journal of Infection
|July 25, 2000
PubMed

Insights

Highly active antiretroviral therapy (HAART) significantly reduced cardiac involvement in HIV patients. This treatment decreased conditions like pericarditis, arrhythmias, and dilated cardiomyopathy.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • HIV/AIDS Research

Background:

  • Cardiac involvement is a significant complication in advanced HIV infection.
  • Previous treatments like nucleoside reverse transcriptase inhibitors (NRTI) were associated with high rates of cardiac issues.

Purpose of the Study:

  • To evaluate the impact of highly active antiretroviral therapy (HAART) on cardiac involvement in HIV-infected patients.
  • To compare the incidence of cardiac complications between NRTI and HAART treatment regimens.

Main Methods:

  • Retrospective analysis of 1042 HIV-infected patients from 1989 to 1998.
  • Comparison of cardiac involvement rates in patients treated with NRTI (1989-1995) versus HAART (1996-1998).

Main Results:

  • Cardiac involvement was observed in 51.8% of patients on NRTI compared to 18.6% on HAART (P < 0.0001).
  • HAART demonstrated a significant reduction in specific cardiac conditions including pericarditis, arrhythmias, and dilated cardiomyopathy.

Conclusions:

  • Highly active antiretroviral therapy (HAART) markedly decreased the incidence of cardiac involvement in HIV patients.
  • The findings underscore the cardiovascular benefits of HAART in managing HIV infection.
Abstract

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...